FDA Approved: NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension from Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Externa
• Otitis Media

Drugs mentioned

• NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION (neomycin and polymyxin B sulfates and hydrocortisone otic suspension)

Snippet

SUPPL AP for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION (NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC)